New drug combo shows promise for tough ovarian cancer
Disease control
Ongoing
This study tests whether combining two drugs, pembrolizumab and lenvatinib, can shrink tumors or slow cancer growth in people with recurrent clear cell ovarian cancer. About 30 participants who have already tried at least one other treatment will receive the drug combination. The…
Phase: PHASE2 • Sponsor: Elizabeth K. Lee MD • Aim: Disease control
Last updated May 01, 2026 15:57 UTC